W Gillies McKenna Selected Research

W Gillies McKenna Research Topics

Disease

32	Neoplasms (Cancer) 01/2021 - 05/2002
9	Hypoxia (Hypoxemia) 01/2021 - 01/2012
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 08/2004
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 05/2002
4	Adenocarcinoma 01/2017 - 05/2013
3	Neoplasm Metastasis (Metastasis) 11/2016 - 06/2008
3	Head and Neck Neoplasms (Head and Neck Cancer) 11/2004 - 05/2002
2	Carcinogenesis 11/2012 - 04/2007
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2018
1	Disease Progression 11/2016
1	Lymphatic Metastasis 01/2016
1	Ichthyin-Related Autosomal Recessive Congenital Ichthyosis 01/2016
1	Squamous Cell Carcinoma of Head and Neck 02/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2012
1	Necrosis 03/2012
1	Hypopharyngeal Neoplasms 03/2012
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Acute Cholecystitis 06/2008
1	Colorectal Neoplasms (Colorectal Cancer) 04/2007
1	Insulin Resistance 09/2005
1	Carcinoma (Carcinomatosis) 09/2005
1	Lung Neoplasms (Lung Cancer) 08/2004
1	Glioma (Gliomas) 11/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2003
1	Brain Neoplasms (Brain Tumor) 11/2003

Drug/Important Bio-Agent (IBA)

6	Farnesyltranstransferase (Farnesyltransferase)IBA 04/2007 - 05/2002
5	Pharmaceutical PreparationsIBA 02/2015 - 11/2003
5	ErbB Receptors (EGF Receptor)IBA 08/2009 - 11/2003
4	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2012 - 09/2005
4	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 07/2008 - 12/2003
3	Nelfinavir (Viracept)FDA Link 01/2016 - 06/2008
3	HIV Protease InhibitorsIBA 01/2016 - 09/2005
3	Phosphotransferases (Kinase)IBA 09/2012 - 11/2003
3	Small Interfering RNA (siRNA)IBA 04/2010 - 09/2005
3	L 778,123IBA 11/2004 - 05/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2012
2	Eosine Yellowish-(YS) (Eosin)IBA 11/2016 - 07/2016
2	Gemcitabine FDA Link 01/2016 - 09/2012
2	MTOR InhibitorsIBA 12/2012 - 03/2012
2	Proteins (Proteins, Gene)FDA Link 03/2012 - 09/2005
2	dactolisibIBA 03/2012 - 01/2012
2	Oncogene Proteins (Oncogene Protein)IBA 07/2008 - 08/2004
2	Dimethylallyltranstransferase (Dimethylallyltransferase)IBA 09/2005 - 08/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2004 - 11/2003
2	Gefitinib (Iressa)FDA Link 11/2003 - 03/2002
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 07/2003 - 03/2002
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Atovaquone (Mepron)FDA Link 01/2021
1	NVP-BKM120IBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	ImmunosorbentsIBA 01/2018
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2018
1	Interferon LambdaIBA 01/2018
1	EnzymesIBA 01/2018
1	RO 3306IBA 01/2018
1	imidazole mustard (BIC)IBA 09/2017
1	fluoromisonidazoleIBA 09/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Carbonic Anhydrase IXIBA 11/2016
1	LigandsIBA 07/2016
1	Radiation-Sensitizing AgentsIBA 01/2016
1	Thiamine (Aneurin)FDA Link 03/2015
1	PyrithiamineIBA 03/2015
1	Cetuximab (Erbitux)FDA Link 02/2015
1	Monoclonal AntibodiesIBA 02/2015
1	Hypoxia-Inducible Factor 1IBA 12/2012
1	CytokinesIBA 12/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012
1	Rad30 proteinIBA 11/2012
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 11/2012
1	3- amino- 6- (4- (methylsulfonyl)phenyl)- N- phenylpyrazine- 2- carboxamideIBA 09/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 03/2012
1	Mechanistic Target of Rapamycin Complex 1IBA 03/2012
1	8- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA 03/2012
1	TOR Serine-Threonine KinasesIBA 03/2012
1	Angiogenesis InhibitorsIBA 01/2012
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012
1	DNA Polymerase thetaIBA 04/2010
1	PI103IBA 07/2008
1	Protease Inhibitors (Protease Inhibitor)IBA 06/2008
1	Transaminases (Aminotransferases)IBA 06/2008
1	Protein Isoforms (Isoforms)IBA 09/2005
1	geranylgeranyltransferase type-I (protein geranylgeranyltransferase)IBA 08/2004
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2003
1	Epidermal Growth Factor (EGF)IBA 11/2003
1	4- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazolineIBA 11/2003
1	Glucose (Dextrose)FDA LinkGeneric 01/2003
1	benzylguanidineIBA 01/2003
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2003

Therapy/Procedure

18	Radiotherapy 01/2019 - 05/2002
8	Therapeutics 01/2018 - 07/2002
3	Adjuvant Chemotherapy 11/2016 - 01/2016
3	Drug Therapy (Chemotherapy) 02/2014 - 09/2012
2	Chemoradiotherapy 01/2016 - 06/2008
1	Pancreatectomy 11/2016
1	Stents 06/2008